BR100 Decreased By (-0.05%)
BR30 Increased By (0.08%)
KSE100 Decreased By (-0.09%)
KSE30 Increased By (0.02%)
AGHA 7.71 Decreased By ▼ -0.21 (-2.65%)
BECO 5.18 Decreased By ▼ -0.02 (-0.38%)
BML 58.00 Decreased By ▼ -1.25 (-2.11%)
BOP 33.43 Decreased By ▼ -0.25 (-0.74%)
CNERGY 10.22 Increased By ▲ 0.41 (4.18%)
CSIL 5.35 Decreased By ▼ -0.07 (-1.29%)
FCCL 54.00 Increased By ▲ 0.48 (0.9%)
FFL 16.38 Decreased By ▼ -0.30 (-1.8%)
FNEL 1.21 No Change ▼ 0.00 (0%)
KEL 7.19 Decreased By ▼ -0.16 (-2.18%)
KOSM 5.57 Decreased By ▼ -0.04 (-0.71%)
LOTCHEM 28.99 Decreased By ▼ -0.12 (-0.41%)
MLCF 95.82 Increased By ▲ 0.32 (0.34%)
NBP 202.61 Decreased By ▼ -1.74 (-0.85%)
NCPL 56.83 Decreased By ▼ -1.41 (-2.42%)
NPL 66.99 Decreased By ▼ -0.80 (-1.18%)
OGDC 318.50 Increased By ▲ 0.56 (0.18%)
PACE 10.66 Decreased By ▼ -0.05 (-0.47%)
PAEL 41.40 Decreased By ▼ -0.43 (-1.03%)
PIBTL 16.55 Increased By ▲ 0.05 (0.3%)
PPL 221.30 Increased By ▲ 1.56 (0.71%)
PRL 47.63 Increased By ▲ 3.04 (6.82%)
PTC 70.50 Decreased By ▼ -0.27 (-0.38%)
SSGC 28.90 Decreased By ▼ -0.03 (-0.1%)
TBL 9.82 Decreased By ▼ -0.02 (-0.2%)
TELE 8.85 Increased By ▲ 0.09 (1.03%)
TPL 17.21 Increased By ▲ 0.76 (4.62%)
TPLP 12.30 Increased By ▲ 0.20 (1.65%)
TREET 22.50 Decreased By ▼ -0.30 (-1.32%)
TRG 59.49 Decreased By ▼ -0.54 (-0.9%)
By

BERLIN: Novartis on Thursday posted a slightly more optimistic full-year earnings forecast, citing the strong growth of drugs such as breast cancer drug Kisqali during the second quarter.

The Swiss drugmaker said it now expects core operating income to grow in the low teens, from the low double-digits cited previously.

Comments

Comments are closed for this article.